A detailed history of Abbrea Capital, LLC transactions in Mckesson Corp stock. As of the latest transaction made, Abbrea Capital, LLC holds 435 shares of MCK stock, worth $251,921. This represents 0.03% of its overall portfolio holdings.

Number of Shares
435
Previous 500 13.0%
Holding current value
$251,921
Previous $269,000 5.58%
% of portfolio
0.03%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$518.81 - $607.81 $33,722 - $39,507
-65 Reduced 13.0%
435 $254,000
Q1 2024

May 07, 2024

BUY
$473.42 - $539.26 $236,710 - $269,630
500 New
500 $269,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $83.2B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Abbrea Capital, LLC Portfolio

Follow Abbrea Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbrea Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abbrea Capital, LLC with notifications on news.